Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ocaratuzumab

Copy Product Info
😃Good
Catalog No. T76821Cas No. 1169956-08-4
Alias LY2469298, LY 2469298, Humanized Anti-MS4A1 Recombinant Antibody, AME133v, AME 133v

Ocaratuzumab (AME-133v) is an Fc-engineered antibody and humanized monoclonal antibody targeting CD20 (Kd≈100 pM), exhibiting antibody-dependent cellular cytotoxicity (ADCC) in chronic lymphocytic leukemia.

Ocaratuzumab

Ocaratuzumab

Copy Product Info
😃Good
Purity: 95%
Catalog No. T76821Alias LY2469298, LY 2469298, Humanized Anti-MS4A1 Recombinant Antibody, AME133v, AME 133vCas No. 1169956-08-4
Ocaratuzumab (AME-133v) is an Fc-engineered antibody and humanized monoclonal antibody targeting CD20 (Kd≈100 pM), exhibiting antibody-dependent cellular cytotoxicity (ADCC) in chronic lymphocytic leukemia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$290-In Stock
5 mg$755-In Stock
10 mg$1,200-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.2% (SDS-PAGE); 98.0% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Ocaratuzumab (AME-133v) is an Fc-engineered antibody and humanized monoclonal antibody targeting CD20 (Kd≈100 pM), exhibiting antibody-dependent cellular cytotoxicity (ADCC) in chronic lymphocytic leukemia.
In vitro
Ocaratuzumab (0.027-20 μg/mL) can concentration-dependently inhibit the binding of biotinylated Rituximab to CD20 on the surface of SKW6.4 cells [1].
SynonymsLY2469298, LY 2469298, Humanized Anti-MS4A1 Recombinant Antibody, AME133v, AME 133v
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetCD20
Chemical Properties
Molecular Weight145.27 kDa
Cas No.1169956-08-4
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Ocaratuzumab | purchase Ocaratuzumab | Ocaratuzumab cost | order Ocaratuzumab | Ocaratuzumab in vitro | Ocaratuzumab molecular weight